Earning Alert - J&J (JNJ) +1.5% as it receives a trio of upgrades - 6/13/12

J&J (JNJ) +1.5% as it receives a trio of upgrades, including one from JPM for the first time in four years. The bank raises J&J to to "overweight" from "neutral," citing the company's recently launched cancer, hepatitis and HIV drugs. Meanwhile, Jefferies increases J&J to "buy" and Raymond James to "outperform."

More Stocks News

For the latest updates on the stock market, visit, 
http://daytradingstock-blog.blogspot.com